Javier Cortés

基本信息

浏览量：308

职业迁徙

个人简介

Research interests: metastatic, breast cancer
From September 2015 to October 2018, he has been Head of the Breast Cancer and Gynecological tumors at Ramon y Cajal University Hospital in Madrid. He is Clinical Investigator of the Breast Cancer Research Program at Vall d’Hebron Institute of Oncology, and Head of Breast Cancer Program, IOB Institute of Oncology, Madrid and Barcelona, Spain.

研究兴趣

论文共 882 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET

A Gennari, E Brain,A De Censi, O Nanni, R Wuerstlein, A Frassoldati,J Cortes, V Rossi, M Palleschi, J L Alberini, F Matteucci, A Piccardo,

Annals of oncology : official journal of the European Society for Medical Oncology (2024)

引用0浏览0WOS引用

Abstract PO1-18-12: Trial in progress: Open-label, randomized, multicenter, phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib for treating locally advanced or ER+/HER2- metastatic breast cancer with an ESR1 mutation

Matthew Goetz,Seth Wander,Thomas Bachelot,Gerald Batist,Javier Cortés,Massimo Cristofanilli,Giuseppe Curigliano, Alexandre de Nonneville, Einav Nili-Gal Yam, Komal Jhaveri,Cynthia Ma,Heather Parsons,

Cancer Researchno. 9_Supplement (2024): PO1-18

引用0浏览0引用

Abstract PO1-06-04: Immune checkpoint inhibitors for triple-negative inflammatory breast cancer (INCORPORATE): an international multicenter retrospective analysis

Carmine Valenza,Dario Trapani,Paola Zagami,Gabriele Antonarelli,Luca Boscolo Bielo,Eleonora Nicolò, Joana Mourato Ribeiro,Lorenzo Guidi,Carolina REDUZZI, Martina Spotti,Elisabetta Munzone,Javier Cortés,

Cancer Researchno. 9_Supplement (2024): PO1-06

引用0浏览0引用

Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trialResearch in context

Antonio Llombart-Cussac,José Manuel Pérez-Garcia,Manuel Ruiz Borrego,Pablo Tolosa,Salvador Blanch,Adela Fernández-Ortega,Ander Urruticoechea,Isabel Blancas,Cristina Saura,Beatriz Rojas,Begoña Bermejo, José Ponce Lorenzo,

EClinicalMedicine (2024): 102520

引用0浏览0引用

Optimal [¹⁸F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial

Geraldine Gebhart,Marleen Keyaerts,Thomas Guiot,Patrick Flamen,Manuel Ruiz-Borrego,Agostina Stradella,Begoña Bermejo,Santiago Escriva-de-Romani, Lourdes Calvo Martínez,Nuria Ribelles, María Fernandez-Abad, Cinta Albacar,

Journal of Nuclear Medicine (2024)

引用0浏览0引用

Disease-free survival as a surrogate for overall survival in HR+/HER2-early breast cancer: A correlation analysis

Michael Untch, David Perol,Erica L. Mayer,Javier Cortes,Arnd Nusch,David Cameron,Carlos Barrios,Thomas Delea, Andrii Danyliv, Namita Mishra, Rhea Gupta,Purnima Pathak,

EUROPEAN JOURNAL OF CANCER (2024)

引用0浏览0引用

Abstract PO2-19-09: INAVO122: a Phase III study of maintenance inavolisib or placebo + pertuzumab + trastuzumab following induction with pertuzumab + trastuzumab + a taxane in patients with PIK3CA-mutated, HER2-positive advanced breast cancer

Sandra Swain, Carlos Barrios,Reva Basho,Giuseppe Curigliano,Nadia Harbeck, Chiun-Shen Huang,Sherene Loi,Nicholas Turner,Jessica Chen, Volkmar Henschel, Simon Warburton, Fabiola Amair-Pinedo,

Cancer Researchno. 9_Supplement (2024): PO2-19

引用0浏览0引用

Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network—Breast dataset (SCAN-B)

G. Villacampa, T. Pascual, F. Brasó-Maristany, L. Paré, O. Martínez-Sáez,J. Cortés, E. Ciruelos,M. Martin, P. Conte, L.A. Carey, A. Fernandez, N. Harbeck,

ESMO Openno. 3 (2024): 102388-102388

引用0浏览0WOS引用

Supplementary Data from Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor–Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti–HER2-Based Therapy

Tomás Pascual,Aranzazu Fernandez-Martinez,Maki Tanioka, M. Vittoria Dieci,Sonia Pernas,Joaquin Gavila,Valentina Guarneri,Javier Cortes,Patricia Villagrasa,Núria Chic, Maria Vidal,Barbara Adamo,

crossref（2024）

引用0浏览0引用

The evolving value assessment of cancer therapies: Results from a modified Delphi study

Myrto Lee, Hugo Larose, Martin Gra, Jon Williams, Anne -Marie Baird, Susan Brown,Johannes Bruns, Russell Clark,Javier Cortes,Giuseppe Curigliano, Andrea Ferris,Louis P. Garrison,

HEALTH POLICY OPEN (2024): 100116-100116

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

副教授

论文共 882 篇作者统计合作学者相似作者